Stay updated on Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial

Sign up to get notified when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page. Removed the prior notices regarding government funding lapses and the earlier Revision: v3.4.1 as part of the site update.
    Difference
    0.4%
    Check dated 2026-02-11T09:44:23.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a government funding lapse notice banner and a site version update banner (Revision: v3.4.1). These are administrative changes and do not affect trial content, eligibility criteria, outcomes, or locations; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:46:08.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated several textual elements (e.g., capitalization of Last Update Submitted that Met QC Criteria and No FEAR Act Data) along with a revision label showing v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:44:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Site revision updated from v3.3.3 to v3.3.4; no changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:37:44.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing study sites across Alabama, California, Colorado, Florida, Massachusetts, Michigan, New Jersey, New York, North Carolina, and Tennessee. Updated the page revision to v3.3.3 and removed the HHS Vulnerability Disclosure link and the previous v3.3.2 reference.
    Difference
    1%
    Check dated 2025-12-23T21:30:38.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The Publications section wording was updated to indicate PubMed-sourced publications are automatically filled, and revision tags were updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:36:33.000Z thumbnail image

Stay in the know with updates to Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.